Schedule 13G ownership disclosure
Collegium Pharmaceutical Inc
Common Stock, Par Value $0.001 Per Share · CUSIP: 19459J104
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Pacer US Small Cap Cash Cows ETF
Shares: 2,138,828 · Class: 5.39%
- Pacer US Small Cap Cash Cows Growth Leaders ETF
Shares: 3,663 · Class: 0.01%
- Pacer Advisors, Inc.
Shares: 2,142,491 · Class: 5.4%
- Joe M. Thomson
Shares: 2,142,491 · Class: 5.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000894189-25-003404
- Form type
- SCHEDULE 13G
- Filer
- COLLEGIUM PHARMACEUTICAL, INC
- CIK
- CIK 1267565
- Filed
- May 02, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership